MAPT and Alzheimer disease: For instance, in a cellular AD model, various oxazole-4-carboxamide/butylated hydroxytoluene hybrids inhibited glycogen-synthase-kinase 3β and reduced Tau-protein phosphorylation in HEK293 cells at sub-micromolar concentrations (Luo et al. 2023).